Protection by flavonoids against anthracycline cardiotoxicity: from chemistry to clinical trials

Author： Bast Aalt Haenen Guido Bruynzeel Anna Vijgh Wim

ISSN： 1530-7905

Source： Cardiovascular Toxicology, Vol.7, Iss.2, 2007-06, pp. : 154-159

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antioxidant defense against anthracycline cardiotoxicity by metallothionein

By Kang Y.

Cardiovascular Toxicology, Vol. 7, Iss. 2, 2007-06 ,pp. : 95-100

Humana Press, Inc

Access to resources Recommend Favorite

Novel antioxidants in anthracycline cardiotoxicity

By Hideg Kálmán Kálai Tamás

Cardiovascular Toxicology, Vol. 7, Iss. 2, 2007-06 ,pp. : 160-164

Humana Press, Inc

Access to resources Recommend Favorite

Anthracycline-Induced Cardiotoxicity

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 6, Iss. 4, 2008-10 ,pp. : 278-281

Bentham Science Publishers

Access to resources Recommend Favorite

Genotyping the risk of anthracycline-induced cardiotoxicity

By Deng Shiwei Wojnowski Leszek

Cardiovascular Toxicology, Vol. 7, Iss. 2, 2007-06 ,pp. : 129-134

Humana Press, Inc

Access to resources Recommend Favorite

Molecular and cellular mechanisms of anthracycline cardiotoxicity

By Chen Billy Peng Xuyang Pentassuglia Laura Lim Chee Sawyer Douglas

Cardiovascular Toxicology, Vol. 7, Iss. 2, 2007-06 ,pp. : 114-121

Humana Press, Inc

Access to resources Recommend Favorite